OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Shane Jacobson: New Cancer Data Reveals Differences Hidden Between Communities

GC-OS 2026: Where Cardio-Oncology Looks to the Future

Karen Knudsen’s Exclusive Commentary on the New Moderna Cancer Vaccine

Shilpa Gupta: Honored that Our Consensus Paper on MIBC Receives June 2026 EU Impact Award

By Women, for Women: The Untold Stories at the Roots of Oncology

Oncology News, Insights, Stories by OncoDaily

Community Oncology
Not To Miss

Highlights From Community Oncology Global Congress 2026, Day 3

ASCO
Lung Oncology

7 Powerful Advances in the ASCO 2026 Guideline for Driver-Positive Stage IV NSCLC

Genentech
Oncology Tech

Genentech Secures Major DualityBio ADC Deal With US$45 Million Upfront

Christopher Jackson and the Question Oncology Cannot Avoid: Who Is Progress Really For?

Registration Open: ODC Life Sciences Invites Clinical Development Leaders to ‘Brazil Unlocked’ in Cambridge, Massachusetts

Manish Shah: Phase 2 NEST Trial Shows Promising Neoadjuvant BOT/BAL Results in Colon Cancer

FDA Approves Daraxonrasib: Here is What Oncologists Have to Say

Ryan Schoenfeld: Personalized mRNA Vaccines Mark a Turning Point in Cancer Immunotherapy

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Multiple Myeloma in 2026: Comprehensive Clinical Update

Voices
Wenchang Yue

Wenchang Yue: Why Recurrence and Progression in Bladder Cancer Require Different Approaches

Fernando Campos: Uniting Research and Clinical Expertise to Advance Musculoskeletal Oncology

IASLC Named Ruth Sudha Moses as a Adi F. Gazdar Fellowship Recipient

Herbert Loong: Whirlwind Visit Back to The Hue University of Medicine and Pharmacy After 11 Years

Balázs Ács: Beyond ER-Positive vs ER-Negative in Breast Cancer

How Well Does Chemoradiation for MIBC Perform Outside the Trial Setting in Older Adults? - SIOG

Nataliya Kovalchuk: The Remarkable Resilience and Modernization of Radiation Oncology in Ukraine

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

Celebrities and Cancer

OncoCalendar

The 2027 Translating Evidence to Action: Elevating Cancer Care Conference

Memorial Sloan Kettering Cancer Center (MSK)

24 Feb
Elevating Cancer Care

NCI Cancer Biomarkers Branch Day: Celebrating 30+ Years of Cancer Biomarkers Research

National Cancer Institute

09 Sep
Cancer Biomarkers

The Translational Research in Clinical Oncology (TRACO) 2026 Course

National Cancer Institute

08 Sep
Clinical Oncology

The 20th Annual New York GU Cancers Congress®

Physicians’ Education Resource® (PER®)

13 Mar
GU Cancers Congress

Cure to Cancer Survivorship: A New Era of Biomarkers, Interventions, and Care Models

Physicians’ Education Resource® (PER®)

06 Feb
Cure to Cancer Survivorship

Immune-oncology
Anti-CD7 CAR T T-ALL/LBL

Anti-CD7 CAR T-Cell Therapy Shows Promising CNS Activity in Relapsed or Refractory T-ALL/LBL

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

CAR T-Cell Therapy Death Rate: Treatment-Related Mortality, Causes of Death, and Risk Factors

CD20 × CD3 Bispecific Antibodies in B-Cell Lymphoma: Real-World Safety, Efficacy, and Healthcare Use in Spain

5 Must-Read Posts About CAR-T This Week

Lung Cancer Immunotherapy: Real-World Survival and Costs in France

INTerpath-001 Trial: Personalized mRNA Cancer Vaccine for Melanoma

Gastrointestinal-Oncology
NEST Trial

Phase 2 NEST Trial: Neoadjuvant BOT/BAL in Localized Colon Cancer

FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer

SKYSCRAPER-07: Atezolizumab ± Tiragolumab After dCRT in Unresectable ESCC

TALENTOP: Liver Resection After Atezolizumab and Bevacizumab in Locally Advanced HCC

10 Must-Read Posts In GI Oncology This Week

ctDNA Identifies High Recurrence Risk After Resection of Stage I–III Biliary Tract Cancer

Comprehensive Genomic Profiling in GI Oncology: Real-World Impact and Challenges

Breast-Oncology
ctDNA

ctDNA During Neoadjuvant Therapy: Toward Real-Time Risk Stratification in Early Breast Cancer

5 Alarming Real-World Findings in HR-Positive, HER2-Low Metastatic Breast Cancer

ELEVATE: Can Elacestrant Become a New Endocrine Backbone After CDK4/6 Inhibition?

ASCO 2026 Guideline: A Risk-Adapted Framework for Early HR-Positive, HER2-Negative Breast Cancer

Artificial Intelligence Brings TILs Into the Digital Era

Oncotype DX-Guided Chemotherapy Associated With Improved Survival in HR+/HER2− Breast Cancer

Insights From I-SPY2 Trial: Dual Immune Checkpoint Blockade Shows Promise in High-Risk ERBB2-Negative Early Breast Cancer

Lung-Oncology
Crizotinib

Adjuvant Crizotinib Fails in Resected ALK-Positive NSCLC: What E4512 Tells Us About Targeted Therapy in Early Disease

7 Powerful Advances in the ASCO 2026 Guideline for Driver-Positive Stage IV NSCLC

When EGFR-Mutant NSCLC Becomes SCLC: Can Immunotherapy Become Relevant Again?

Are We Irradiating the Immune System? Thymic Dose Emerges as a Potential Risk Factor in NSCLC

Ivonescimab Plus Chemotherapy Shows Powerful Benefit After EGFR-TKI Resistance in Advanced Lung Cancer

Dato-DXd in Lung Cancer: International Experts Define New Strategies to Manage ADC Toxicities

Lung Cancer Screening in Women: 5 Breakthrough Insights Highlight New Risk Groups

OncoDaily TV
WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Fighting Cervical Cancer

From Engineering to Fighting Cervical Cancer

Dr. Beatrice Addai Wiafe

Fighting Cancer With Peace And Love: Dr. Beatrice Addai Wiafe

Maggie Smith breast cancer

Dame Maggie Smith and Courageus Breast Cancer Journey: Filming Harry Potter During Chemotherapy

Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Empowering Oncologist

Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll

Dr. C.S. Pramesh

The Power of Collaboration in Fighting Cancer: Dr. C.S. Pramesh

Tommy Bramley

Making Innovative Oncology Therapies Accessible for All Patients: Tommy Bramley

Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Not To Miss
Community Oncology

Highlights From Community Oncology Global Congress 2026, Day 3

Highlights From Community Oncology Global Congress 2026, Day 2

FDA Approves Takeda’s Mimrylo (Rusfertide) for Polycythemia Vera

Highlights From Community Oncology Global Congress 2026, Day 1

China NMPA Conditionally Approves HUTCHMED’s ATLED (Fanregratinib) for FGFR2-Altered Intrahepatic Cholangiocarcinoma

FDA Approves Rasonque (Daraxonrasib), First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer

Agenus Reports No Recurrences and Deep Pathologic Responses With Neoadjuvant BOT+BAL in Resectable Colon Cancer

OncoGrants
Alcohol-Related Cancer Risk

NCI–NIAAA Population Approaches to Reducing Alcohol-Related Cancer Risk R01 Grant 2026

Incretin Mimetics R01 Grant

NCI Mechanisms That Impact Cancer Risk With Incretin Mimetics R01 Grant 2026

NCI

NCI Early-Stage Innovative Cancer Technology Development R61 Grant 2026

Cancer Epidemiology Cohort

NCI Research Opportunities in Cancer Epidemiology Cohort Studies U01 2026

Cancer Health Disparities

NCI Basic Research in Cancer Health Disparities R01 Grant 2026

Science Research Education Program

NCI Youth Enjoy Science Research Education Program 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Sandy Carmona Lozano

Sandy Carmona Lozano

Oncologists Location Pueblo Libre, Peru
Charbel Matar

Charbel Matar

Oncologists Location Washington, USA
Leandro Jonata de Carvalho Oliveira

Leandro Jonata de Carvalho Oliveira

Oncologists Location São Paulo, Brazil
Wade Swenson

Wade Swenson

Oncologists Location Staples, USA
Vincenza Conteduca

Vincenza Conteduca

Oncologists Location Foggia, Italy
Fred Hirsch

Fred Hirsch

Oncologists Location New York, USA
Miriam Mutebi

Miriam Mutebi

Oncologists Location Nairobi, Kenya
Juliet Lumati

Juliet Lumati

Oncologists Location Illinois, USA

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Jeff Allen

Jeff Allen: New Evidence Supporting ctDNA as an Early Indicator of Treatment Benefit

William Dale

William Dale: Geriatric Assessment and Management Linked to Better Coping and Clinical Outcomes

Patrick Forde

Patrick Forde: Crizotinib Fails Where Alectinib Succeeded

Jacob Scott

Jacob Scott: Bringing Rectal Cancer Radiotherapy Into the Genomic Era

Valsamo Anagnostou

Valsamo Anagnostou: New Molecular Response Marker Could Transform Immunotherapy Monitoring

Pashtoon Kasi

Pashtoon Kasi: NEST Trial Reports 100% Disease-Free Survival to Date in Localized Colon Cancer

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts

Hematology

10.69690/ODMJ-018-0826-7945

Plasma cell survival: The impact of extracellular ATP
Abstracts

Breast Cancer

10.69690/ODMJ-018-0826-7965

A Systematic Comparison of ICG Fluorescence vs Dual-Tracer Sentinel Lymph Node Biopsy in Breast Cancer Staging
Abstracts